Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Exscientia Ltd ADR
EXAICurrent price
5.31 USD
-0.36 USD (-6.35%)
Last closed
5.61 USD
Company
www.exscientia.ai
ISIN
US30223G1022
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
711 671 680 USD
Yield for 12 month
-11.20 %
1Y
3Y
5Y
10Y
15Y
EXAI
Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. The company's lead product candidate GTAEXS617, a CDK7 inhibitor, which is currently in a Phase 1/2 trial to manage the potential toxicities associated with CDK7 as well as optimizing pharmacokinetics for maximizing on-target efficacy. It is also involved in the development of EXS4318, a PKC-theta inhibitor, under Phase 1 clinical trial for inflammation and immunology indications; EXS74539, a LSD1 inhibitor, under preclinical studies for SCLC, AML, and potential additional indications; EXS73565, a MALT1 inhibitor, under preclinical studies for multiple hematology indications; and DSP-0038, currently in Phase 1 studies. The company has collaboration agreements with Merck KGaA, Bristol Myers Squibb, Sanofi, Bill & Melinda Gates Foundation, Charité " Universitätsmedizin Berlin, Rallybio, and GT Apeiron Therapeutics. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom. Address: The SchrOedinger Building, Oxford, United Kingdom, OX4 4GE
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.35 USDP/E ratio
–Dividend Yield
–Current Year
+25 414 053 USD
Last Year
+34 508 738 USD
Current Quarter
+5 685 854 USD
Last Quarter
+6 806 555 USD
Current Year
-29 003 589 USD
Last Year
-7 656 954 USD
Current Quarter
-4 297 522 USD
Last Quarter
-2 723 909 USD
Key Figures EXAI
1 year
3 years
5 years
10 years
EBITDA
-136 952 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-18.86 %
PEG Ratio
–
Return On Equity TTM
-36.34 %
Wall Street Target Price
5.35 USD
Revenue TTM
21 021 000 USD
Book Value
2.83 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
47 %
Dividend Yield
–
Gross Profit TTM
10 247 000 USD
Earnings per share
-1.33 USD
Diluted Eps TTM
-1.33 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics EXAI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EXAI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation EXAI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
13.1947
Price Sales TTM
33.8553
Enterprise Value EBITDA
-1.6591
Price Book MRQ
1.8679
Financials EXAI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EXAI
For 52 weeks
3.8 USD
7.91 USD
50 Day MA
5 USD
Shares Short Prior Month
2 887 920
200 Day MA
5.31 USD
Short Ratio
3.94
Shares Short
2 920 514
Short Percent
4.47 %
BeatStart